Suchergebnisse - "Fajgenbaum, David C"

PubPharm (8)

1

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease

enthalten in: Hematology. American Society of Hematology. Education Program | 2018

von Fajgenbaum, D.

2

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease

enthalten in: Blood | 2018

von Fajgenbaum, D.

3

Castleman Disease Pathogenesis

enthalten in: Hematology/oncology clinics of North America | 2018

von Fajgenbaum, D. | Shilling, D.

4

TAFRO syndrome : New subtype of idiopathic multicentric Castleman disease

enthalten in: Bosnian journal of basic medical sciences | 2017

von Srkalovic, G. | Marijanovic, I. | Srkalovic, M. | +1

5

Idiopathic multicentric Castleman's disease : a systematic literature review

enthalten in: The Lancet. Haematology | 2016

von Liu, A. | Nabel, C. | Finkelman, B. | +7

CommentIn: Lancet Haematol. 2016 Apr;3(4):e150-2. - PMID 27063967

6

Siltuximab : a targeted therapy for idiopathic multicentric Castleman disease

enthalten in: Immunotherapy | 2016

von Fajgenbaum, D. | Kurzrock, R.

7

Taking Control of Castleman Disease : Leveraging Precision Medicine Technologies to Accelerate Rare Disease Research

enthalten in: The Yale journal of biology and medicine | 2015

von Newman, S. | Jayanthan, R. | Mitchell, G. | +8

8

HHV-8-negative, idiopathic multicentric Castleman disease : novel insights into biology, pathogenesis, and therapy

enthalten in: Blood | 2014

von Fajgenbaum, D. | van Rhee, F. | Nabel, C.

1
[1]